California Florida Pennsylvania Virginia Wyoming

Canvas Dx

Canvas Dx

Canvas Dx is the culmination of years of research by leading behavior health experts, conducted in labs at Harvard and Stanford. With FDA-Authorization in 2021 and a rich history of rigorous research, including multiple publications in peer-reviewed medical journals, Canvas Dx stands as a critical milestone in the field of autism.

The technology uses information from various sources to assess a child’s social-communication skills and behavior, enabling the early identification of autism. This includes parent provided videos of the child, along with questionnaires from our physician, all processed using cutting-edge technology.

Cognoa developed and validated Canvas Dx technology using data from a diverse population of children across the U.S. from different social, economic, ethnic, and gender groups. This commitment to inclusivity ensures that our findings are generalizable and equitable.

Scroll to Top